Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,091,449
+$609,832 QoQ
Shares Held
24,207
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#1,194
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $11,088,191 across 9 Drug Manufacturers - General names. ABBV ranks #1 (54.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
24,207 | $6,091,449 | |
| 2 | AMGN |
Amgen Inc
|
8,625 | $3,123,285 | |
| 3 | JNJ |
Johnson & Johnson
|
4,871 | $1,237,087 | |
| 4 | LLY |
ELI LILLY & Co
|
287 | $344,236 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,497 | $189,130 | |
| 6 | PFE |
Pfizer Inc
|
2,210 | $53,216 | |
| 7 | MRK |
Merck & Co., Inc.
|
297 | $38,164 | |
| 8 | GSK |
GSK plc
|
221 | $11,584 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,091,449 | 24,207 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,481,617 | 25,204 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $5,743,781 | 25,138 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,896,397 | 25,466 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,791,780 | 25,815 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $5,463,862 | 26,078 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,790,081 | 26,956 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,346,178 | 27,072 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,690,385 | 27,346 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $4,931,450 | 27,081 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,155,055 | 26,812 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $4,060,096 | 27,238 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,738,083 | 27,745 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,415,505 | 27,706 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $4,426,174 | 27,388 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,823,240 | 28,487 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $4,375,781 | 28,570 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,661,473 | 28,755 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,888,011 | 28,715 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $3,005,042 | 27,858 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $3,142,768 | 27,901 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $2,977,781 | 27,516 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,838,617 | 26,492 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $2,348,725 | 26,815 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $2,698,280 | 27,483 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,125,548 | 27,898 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||